Newsmeme!
Discover News you didn't know existed
Glucagon
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
ONGLYZA™ (Saxagliptin) Receives Positive Opinion In Europe For The Treatment Of Type 2 Diabetes
Published July 4, 2009, 4:11 am, Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA™ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.
Novo Nordisk A/S -- Regulatory Approval
Published July 3, 2009, 2:03 am, Marketwire
BAGSVAERD, DENMARK--(Marketwire - July 3, 2009) - Novo Nordisk's Victoza® (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults. The authorisation covers all 27 European Union member states. Victoza® is the brand name approved in Europe for ...
My Pharmiweb.com
Published July 1, 2009, 2:04 am, PharmiWeb
OSAKA, Japan, June 29, 2009 – Takeda Pharmaceutical Company Limited (Takeda) today announced that it submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new drug application (NDA) of fixed-dose combination (FDC) of alogliptin and pioglitazone HCl (generic name, tradename in Japan: ...
Takeda seeks additional indication of alogliptin for combo therapy with thiazolidinediones
Published June 30, 2009, 1:48 am, PharmaBiz
Takeda Pharmaceutical Company Limited (Takeda) announced that it submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new drug application (NDA) of fixed-dose combination (FDC) of alogliptin and pioglitazone HCl (generic name, tradename in Japan: Actos) to the Ministry of Health, ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |